Interestingly, prostate-specific membrane antigen (PSMA, also called FOLH1), a glutamate carboxypeptidase, is also involved in glutamate metabolism and has been proven to influence the progression and metastasis of prostate cancer [31–33]. The gene discussed is FOLH1; the disease is prostate carcinoma.